BioMarin Pharmaceutical Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BMRN Nasdaq 2834 http://www.bmrn.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioMarin Pharmaceutical Inc.

BioMarin to Host Third Quarter 2021 Financial Results Conference Call and Webcast on Wednesday, October 27 at 4:30pm ET - Oct 12th, 2021 12:30 pm
Hedge Funds Are Nibbling On BioMarin Pharmaceutical Inc. (BMRN) - Oct 4th, 2021 4:32 pm
BioMarin Hires Industry Veterans to Fill Key Roles in R&D and Technical Operations - Oct 4th, 2021 12:31 pm
Deaths Raise Safety Concerns Around Gene Therapy - Oct 1st, 2021 9:30 am
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioMarin Pharmaceutical Inc. - BMRN - Sep 21st, 2021 8:54 pm
Biotech Stock Roundup: MRNA Submits Vaccine Data, BMRN Down on Clinical Hold & More - Sep 8th, 2021 3:39 pm
BioMarin Stock Fell Because Cancer Concerns Are a New Worry for Gene Therapy - Sep 7th, 2021 10:07 pm
BioMarin (BMRN) Phenylketonuria Gene Therapy on Clinical Hold - Sep 7th, 2021 2:08 pm
BioMarin Plunges as FDA Puts Clinical Hold on a Gene Therapy Study - Sep 7th, 2021 10:35 am
FDA Slaps Clinical Hold on BioMarin's Gene Therapy For Genetic Metabolism Disorder - Sep 7th, 2021 10:11 am
U.S. FDA Placed a Clinical Hold on BMN 307 Phearless Phase 1/2 Gene Therapy Study in Adults with PKU Based on Interim Pre-clinical Study Findings - Sep 6th, 2021 6:00 am
BioMarin's (BMRN) Dwarfism Drug Gets Approval in Europe - Aug 30th, 2021 3:02 pm
Stock Market News for Aug 30, 2021 - Aug 30th, 2021 1:38 pm
Why Is BioMarin (BMRN) Up 0.4% Since Last Earnings Report? - Aug 27th, 2021 3:31 pm
European Commission Approves BioMarin’s VOXZOGO® (vosoritide) for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close - Aug 27th, 2021 1:51 pm
UPDATE 2-Biomarin's drug wins Europe's first approval for type of dwarfism - Aug 27th, 2021 1:16 pm
With EPS Growth And More, BioMarin Pharmaceutical (NASDAQ:BMRN) Is Interesting - Aug 26th, 2021 10:23 am
BioMarin to Participate in Three Upcoming Virtual Investor Conferences - Aug 25th, 2021 12:30 pm
Get Ready for a Potential Double in This Biopharmaceutical Stock in the Next 6 to 12 Months - Aug 20th, 2021 10:19 am